HILS Stock Price History and Quote Analysis: Insights for Investors
Hillstream BioPharma, Inc.
Stock Price Today
Hillstream BioPharma, Inc. (HILS) stock surged +5.66%, trading at $0.24 on NASDAQ, up from the previous close of $0.22. The stock opened at $0.23, fluctuating between $0.22 and $0.24 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
Company Information
| Employees | 1 |
| Beta | 0 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Hillstream BioPharma, Inc. (NASDAQ: HILS) stock price is $0.24 in the last trading session. During the trading session, HILS stock reached the peak price of $0.24 while $0.22 was the lowest point it dropped to. The percentage change in HILS stock occurred in the recent session was 5.66% while the dollar amount for the price change in HILS stock was $0.01.
The NASDAQ listed HILS is part of Biotechnology industry that operates in the broader Healthcare sector. Hillstream BioPharma, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Sireesh Appajosyula Pharm.D.
Chief Operating Officer & Director
Mr. Randy D. Milby MBA
Pres, Chairman & Chief Executive Officer
HILS's closing price is 37.55% higher than its 52-week low of $0.17 where as its distance from 52-week high of $2.65 is -91.06%.
Number of HILS employees currently stands at 1.
Official Website of HILS is: https://www.hillstreambio.com
HILS could be contacted at phone 908 955 3140 and can also be accessed through its website. HILS operates from 1200 Route 22 East, Bridgewater, NJ 08807, United States.
HILS stock volume for the day was 313.2K shares. The average number of HILS shares traded daily for last 3 months was 684.78K.
The market value of HILS currently stands at $4.17M with its latest stock price at $0.24 and 17.6M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com